Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00813956
Brief Title: A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer

First Submitted : December 19, 2008
First Submitted that Met QC Criteria : December 19, 2008
First Posted : December 23, 2008 (Estimate)

Certification/Extension First Submitted : February 17, 2016
Certification/Extension First Submitted that Met QC Criteria : February 17, 2016
Certification/Extension First Posted : March 17, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 17, 2016
Last Update Posted : March 17, 2016 (Estimate)